Which hedge funds own ABOS? ACUMEN PHARMACEUTICALS INC, Q2 2026 13F holders
6 of the hedge funds tracked by WhaleCreep disclosed a position in ABOS (ACUMEN PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $58.3m in total. The largest holder by portfolio weight is RA Capital Management at 0.5% of its book. 2 managers opened a new position this quarter: Bronte Capital, Citadel Advisors. 2 exited: Brevan Howard Capital Management, Point72 Asset Management LP.
6tracked managers holding
2opened this quarter
2exited this quarter
Which hedge funds hold ABOS? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 0.5% | $56.1m | 20,992,669 | 0% | held |
| Bronte Capital | Q2 2026 | 0.0% | $28.6k | 10,716 | – | new |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.8m | 675,025 | 42% | added |
| Millennium Management | Q2 2026 | 0.0% | $161.8k | 60,598 | -91% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $128.5k | 48,114 | -75% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $136.3k | 51,049 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $36.3k |
| Point72 Asset Management LP | 0.0% | $159.0k |
How has hedge fund ownership of ABOS changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $58.3m |
| Q1 2026 | 6 | $52.9m |
| Q4 2025 | 3 | $32.5m |
| Q3 2025 | 2 | $26.5m |
| Q2 2025 | 2 | $17.6m |
| Q1 2025 | 2 | $16.7m |
| Q4 2024 | 2 | $26.1m |
| Q3 2024 | 2 | $37.8m |
| Q2 2024 | 2 | $37.0m |
| Q1 2024 | 1 | $60.5m |
| Q4 2023 | 1 | $57.3m |
| Q3 2023 | 2 | $62.3m |
| Q2 2023 | 2 | $47.2m |
| Q1 2023 | 4 | $41.6m |
| Q4 2022 | 4 | $55.4m |
| Q3 2022 | 4 | $107.0m |
Counts every tracked manager that disclosed ABOS in that quarter's filing, including managers that have since stopped filing.